HIGHLIGHTS
- who: Chemotherapy on Locally Advanced and collaborators from the Department of General Surgery, Taizhou People`s Hospital, Taizhou, China have published the research work: Efficacy of DC-CIK Immunotherapy Combined with Chemotherapy on Locally Advanced Gastric Cancer, in the Journal: Journal of Oncology of 12/07/2022
- what: In the present study, the clinical efficacy and safety of DC-CIK immunotherapy combined with oxaliplatin-5fluorouracil chemotherapy in the treatment of locally advanced gastric cancer (LAGC) were explored, and the effect of treatment on the immune function of patients was analyzed, hoping to provide a stronger . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.